Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope and definitions
1.3 Base estimates and working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Mice model industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Mice Type trends
2.1.3 Technology trends
2.1.4 Application trends
2.1.5 Use trends
2.1.6 End-use trends
2.1.7 Regional trends
Chapter 3 Mice Model Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 – 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rise in the advancements in gene editing tools
3.3.1.2 Rising demand for humanized mice models
3.3.1.3 Physiological similarities between human and Mice
3.3.1.4 Growing consumption of personalized medicine in developing and developed countries
3.3.2 Industry pitfalls & challenges
3.3.2.1 Ongoing developments of alternative methods to animal testing
3.3.2.2 Strict regulations and guidelines
3.3.2.3 Growing opposition on mice testing by several organizations
3.4 Growth potential analysis
3.4.1 By mice type
3.4.2 By technology
3.4.3 By application
3.4.4 By use
3.4.5 By end-use
3.5 COVID-19 impact analysis
3.6 Technological advances in using mice models for studying ovarian cancer
3.7 Advantages and disadvantages of in vivo mouse models
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company positioning matrix
4.4 Competitive analysis of major market players
4.5 Strategic outlook matrix
4.6 Strategy dashboard, 2022
Chapter 5 Mice Model Market, By Mice Type
5.1 Key mice type trends
5.2 Inbred
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.3 Outbred
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.4 Knockout
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.5 Hybrid
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.6 Other mice types
5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6.2 Market estimates and forecast, 2018 - 2032 (000' Units)
Chapter 6 Mice Model Market, By Technology
6.1 Key technology trends
6.2 CRISPR
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Microinjection
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Embryonic stem cell injection
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Nuclear transfer
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Other technologies
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Mice Model Market, By Application
7.1 Key application trends
7.2 Research & development
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.2 Infectious diseases
7.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.3 Immunological diseases
7.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.4 Cancer
7.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.5 Cardiovascular diseases
7.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.6 Diabetes
7.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.7 Genetic diseases
7.2.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.8 Neurological diseases
7.2.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.9 Other diseases
7.2.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Production and quality control
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Academics
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Other applications
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Mice Model Market, By Use
8.1 Key use trends
8.2 Human
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Veterinary
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Mice Model Market, By End-use
9.1 Key end-use trends
9.2 Companies
9.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.2.2 Pharmaceutical
9.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.2.3 Biotechnology
9.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.2.4 Cosmetics
9.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.2.5 Other companies
9.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.3 Organisations
9.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.3.2 Government
9.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.3.3 Non-government
9.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.4 Academic and research institutes
9.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.5 Contract research organizations (CRO)
9.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 10 Mice Model Market, By Region
10.1 Key regional trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Switzerland
10.3.7 Netherlands
10.3.8 Czech Republic
10.3.9 Poland
10.3.10 Belgium
10.3.11 Finland
10.3.12 Hungary
10.3.13 Denmark
10.3.14 Ireland
10.3.15 Sweden
10.3.16 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 Australia
10.4.4 South Korea
10.4.5 New Zealand
10.4.6 Taiwan
10.4.7 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Israel
10.6.5 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Charles River Laboratories International, Inc River
11.2 Taconic Biosciences, Inc.
11.3 Janvier Labs
11.4 genOway
11.5 Hera Biolabs
11.6 TransViragen Inc.
11.7 The JACKSON LABORATORY
11.8 Inotiv
11.9 Allentown LLC
11.10 Harbour Biomed
11.11 PolyGene
